PRL and pituitary tumor: By inhibiting the activity of TOPK in vitro, it was found that the inhibition of TOPK could reduce proliferation and migration of pituitary tumor cells, induce apoptosis and cell cycle arrest, and decrease PRL production at the gene, protein and secretion levels.